|
|
||||||||
Ann Thorac Surg 2003;76:309-314
© 2003 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Berne, Switzerland
b Institute of Anesthesiology, Berne, Switzerland
c Division of Neonatology, University Hospital, Berne, Switzerland
d Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA
* Address reprint requests to Dr Immer, Department of Cardiovascular Surgery, University Hospital, 3010 Berne, Switzerland
e-mail: franzimmer{at}yahoo.de
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In 1981 Pyeritz [12] reported that there was no higher rate of complications during pregnancy in a group of Marfan syndrome patients with minor cardiovascular involvement. His recommendations were that women with minor cardiovascular involvement and an aortic root diameter of less than 4 cm can be counseled of a relatively small risk of aortic dissection. These recommendations have been adopted as guidelines in obstetric textbooks [13, 14]. In 1995 Rossiter and coworkers [5] subsequently published the first prospective longitudinal evaluation of pregnancy in patients with Marfan syndrome. This study included 45 pregnancies in 21 Marfan patients over a 10-year period. Pyeritzs recommendations were confirmed [5]. Not only was the absolute diameter of the aortic root important, but also the rapidity of aortic dilatation was important in Marfan syndrome patients, and should be taken into account [15]. Presently all recommendations focus on the occurrence of acute Type A dissection in Marfan patients. No recommendations are available concerning Type B dissection. Furthermore, Marfan syndrome is responsible for up to 50% of the reports [6, 8] published in the literature.
The aim of this study was to evaluate risk factors for the occurrence of acute Type A and Type B aortic dissection during pregnancy in a large group of patients pooled from the literature, and including patients from the Mayo Clinic (Rochester, MN, USA) and the University Hospital Berne (Berne, Switzerland) to analyze the role of bicuspid aortic valve disease (BAVD), and to review the recommendations concerning the modality of treatment in these patients.
| Patients and methods |
|---|
|
|
|---|
Between January 1983 and August 2002, 296 consecutive patients were operated at the Mayo Clinic for Type A aortic dissection. Twelve women (4.1%) were under the age of 45 years and 1 patient was pregnant. One intervention on the thoracoabdominal aorta was made in a patient in whom acute Type B dissection occurred during delivery.
In the same time period 275 consecutive patients were operated for acute Type A aortic dissection at the University Hospital Berne. Eight women (2.9%) were under the age of 45 years. Four of them were pregnant. In this time period 1 patient had to be operated for acute Type B dissection, occurring 1 day after delivery.
Including our experiences, a total of 45 women (78.9%) with acute Type A dissection and 12 with Type B dissection (21.1%) associated with pregnancy, were analyzed.
Methods
We focused on the following variables: diagnosis (Type A dissection, Type B dissection, aneurysm), presence of BAVD, age, presence of a systemic disease (Marfan syndrome, Ehlers-Danlos), history of hypertension, severity of aortic regurgitation, diameter of aortic root, gestational week, mode of delivery (spontaneous vaginal or cesarean section), cardiac surgical procedure (including technical details if available), maternal outcome, and neonatal outcome. The diagnosis of Marfan syndrome in our patients was based on the criteria published by De Paepe and his colleagues [38], and for the diagnosis of Ehlers-Danlos we referred to the revised nosology, Villefranche 1997, published in 1998 [39].
| Results |
|---|
|
|
|---|
|
|
|
| Comment |
|---|
|
|
|---|
As these modifications occur in every pregnancy, it may be assumed that those afflicted by aortic dissection have some additional etiologic factors, such as an inherent defect in the arterial wall. Patients with Marfan syndrome have a mutation within the fibrillin gene on chromosome 15q21 [49], the connective tissue disorder often affects cardiovascular system and may favor aortic root dilatation and aortic dissection. Abnormal biophysical properties of the aorta in patients with Marfan syndrome were found in normal-sized aortas in patients with magnetic resonance flow mapping [50]. There was decreased aortic distensibility and increased flow wave velocity in the aorta, compared with healthy control patients. This study suggests an additional wall stress in patients with Marfan syndrome, which may favor dissection during pregnancy.
Effects of bicuspid aortic valve
The incidence of documented Marfan syndrome in this review was 44% in patients with Type A dissections and 42% in patients with Type B dissections. The presence of bicuspid aortic valve, found in 2 of 5 patients in this study with acute Type A dissection and in 2 patients in the literature, may be another reason for the occurrence of aortic dissection during pregnancy. Abnormal elastic properties, similar to the findings in patients with Marfan syndrome, have been described recently by two groups [51, 52]. Similar findings have been reported by Parai and his colleagues [53], who demonstrated significantly less elastic tissue in aortas of bicuspid aortic valve patients. The results from Okamoto and associates [54] also suggest that biomechanical properties of dilated human ascending aorta are also reduced in patients with bicuspid aortic valve. A recent study found similar modifications of the aortic root and the ascending aorta in patients after repaired tetralogy of Fallot [55], which may increase the risk of dissection in this collective of patients. These changes in mechanical properties are influenced by age, which may be a reason why the average maternal age is around 31 years in dissected patients, compared with Marfan syndrome patients with bicuspid aortic valves, who tend to be younger (p = ns) and dissection occur earlier in gestation (26.8 ± 7.6 vs 31.5 ± 5.9 weeks; p < 0.05).
Differences in patient characteristics in type A and B dissection
We found no differences between patients with Type A and Type B dissection. They were similar in age (31.1 ± 5.1 vs 31.1 ± 4.2 years), gestational week at the occurrence of dissection (31.4 ± 7.5 vs 31.6 ± 7.3 weeks), and incidence of systemic disease (44% vs 42%). As described in the literature, Type B dissection is less frequent than Type A dissection [6]. This is similar to our findings of 79% acute Type A dissections and 21% acute Type B dissections. It may be speculated that this may be due to difficulty in diagnosis. Type B dissections are less symptomatic than Type A dissections and are probably underreported in the literature: they often do not require immediate surgery and are, therefore, less spectacular than Type A dissection.
Patients with enlarged aortic roots (> 4 cm, or less in patients with a low body surface area [BSA]) [56, 57] or an increasing size of the aortic root during pregnancy are at risk for the occurrence of Type A dissection. Beside the presence of a systemic disease, no risk factor can aid the clinician finding out if patients are at higher risk for Type B dissection.
Modality of treatment
Based on this review, we propose the following guidelines for treatment. If aortic root enlargement (> 4cm, or less in patients with a low BSA) is known in a Marfan syndrome patient or in a patient known to have a bicuspid aortic valve, preconceptional counseling should recommend prepregnancy surgery. Elective aortic root replacement can be performed with very low morbidity and mortality in Marfan syndrome patients [58, 59]. By choosing the surgical technique one has to remember that the composite graft introduces the need for anticoagulation, and warfarin has clear potential for teratogenecity, although valve sparing procedures and homografts have their own issues, which have to be considered.
Based on the data from Lind and Wallenburg [9] preconceptional counseling took place only in 25% of Marfan syndrome patients before pregnancy. If aortic root enlargement is found in a pregnant patient, close echocardiographic surveillance and blood pressure management is mandatory. If the aortic root is larger than 4 cm or a progression of aortic root enlargement is observed, a beta-receptor blocking drug should be administered. Beta-receptor blocking drugs may have important maternal and fetal side effects and should be used cautiously [6062]. They can increase the uterine tone and contractility and decrease umbilical blood flow. Furthermore, although propranolol is probably not a teratogen, it is associated with adverse fetal and neonatal effects and use should be decided on an individual basis [60, 61, 63]. The primary aim of intrapartum management in patients with Marfan syndrome or a bicuspid aortic valve and aortic root enlargement is to reduce the cardiovascular stress of labor and delivery. In patients at risk, elective fetal lung maturation should be induced at 26-weeks gestation. Hospitalization of high-risk patients should be considered between 28 and 32 weeks. When possible, consultation with a neonatologist should be also arranged at this time so that the parents can be adequately informed about the treatment options and risks for a preterm infant. We recommend delivery by cesarean section in regional anesthesia to prevent blood pressure peaks, which may induce dissection. Aortic root surgery should be done a few days after delivery. Close monitoring and administration of beta-blocking drugs should continue up to 3 months postpartum. Dissection (Type A or Type B) can occur during this period. In our experience, before 30-week gestation, aortic repair with the fetus in utero is recommended. The use of intraoperative cardiotocography (CTG) for monitoring fetal heart beats during aortic surgery (or other type of surgery) may be an option to document the actuarial situation of the child. We recently reported a patient in which misinterpretation of the CTG led to an emergency caesarean section [64]. As recommended by Becker [65], high-flow, high-pressure normothermic perfusion and a perfusion index of 3.0 during cardiopulmonary bypass is probably safest for the fetus. Hypothermia decreases placental blood flow [66] and may cause fetal bradycardia, leading to intrauterine death or severe hypoxic-ischemic fetal insult [31]. However, avoiding hypothermia precludes an open distal aortic repair, which is preferable [67]. A good compromise may be the use of antegrade cerebral perfusion for brain protection and moderate hypothermia (28°C) as described by Bachet and Guilmet [68]. There are several reports of successful hypothermia or deep hypothermic circulatory arrest during pregnancy (before 28-weeks gestation). After 30-weeks of gestation, immediate cesarean section followed directly by cardiac surgery seems to be the most promising option to save the live of the mother and her unborn child. No serious complications have been reported in the literature by adapting this modality of treatment. Cardiac surgery should be performed in a hospital in which neonatal intensive care facilities are available. For safety reasons cardiopulmonary bypass can be installed simultaneously during cesarean section (femoral or axillary cannulation). In patients with Type B dissection, conservative treatment is recommended in the absence of rupture or malperfusion. A high-incidence of fetal demise has been reported. This is probably due to a partial occlusion of the internal iliac artery or the ovarian arteries decreasing placental blood flow. Complications of Type B dissections require immediate surgical intervention as per acute Type A dissections.
Conclusions
Patients with a known bicuspid aortic valve and enlarged aortic root should to be counseled like Marfan syndrome patients. Normal sized patients with an aortic root size more than 4 cm (or smaller in patients with low BSA), or an increase of aortic root size during pregnancy are at high risk for the occurrence of aortic dissection, mainly in the third trimester. If possible, surgical repair of the enlarged aortic root should be done prepartum. In patients in whom the diagnosis of an enlarged aortic root is made during pregnancy, a close echocardiographic follow-up (4 to 6 weeks) is mandatory. In an aortic root more than 4 cm or with increasing size, beta-blocking agents should be prescribed but with caution. Development of the child should be monitored. In patients at risk elective fetal lung maturation should be induced at 26-weeks gestation and hospitalization of high-risk patients should be considered between 28 and 32 weeks. During pregnancy and during delivery, hypertensive blood pressure should be prevented; we recommend a cesarean section under regional anesthesia in all patients at risk. Aortic root surgery should be performed a few days after delivery. In case of acute Type A dissection before 30 weeks of gestation immediate surgery should be performed, and after 30-weeks gestation cesarean section followed by cardiac surgery is the best modality of treatment. Close monitoring and the administration of beta-blocking agents is mandatory up to 3 months postpartum, as late dissections may occur in this time period.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. E. D. Shirley and P. D. Sponseller Marfan Syndrome J. Am. Acad. Ortho. Surg., September 1, 2009; 17(9): 572 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goland and U. Elkayam Cardiovascular Problems in Pregnant Women With Marfan Syndrome Circulation, February 3, 2009; 119(4): 619 - 623. [Full Text] [PDF] |
||||
![]() |
P. H. Lin, T. T. Huynh, P. Kougias, J. Huh, S. A. LeMaire, and J. S. Coselli Descending Thoracic Aortic Dissection: Evaluation and Management in the Era of Endovascular Technology Vascular and Endovascular Surgery, February 1, 2009; 43(1): 5 - 24. [Abstract] [PDF] |
||||
![]() |
B. Birgit, H. Julius, R. Carsten, S. Maryam, F. Gabriel, K. Victoria, F. Margareta, and H. Outi Fertility Preservation in Girls with Turner Syndrome: Prognostic Signs of the Presence of Ovarian Follicles J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
M. Shihata, V. Pretorius, and R. MacArthur Repair of an acute type A aortic dissection combined with an emergency cesarean section in a pregnant woman Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 938 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
S. Pagni, B. L. Ganzel, and T. Tabb Hemiarch aortic replacement for acute type A dissection in a Marfan patient with twin pregnancy Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 740 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Patel and G. M. Deeb Ascending and Arch Aorta: Pathology, Natural History, and Treatment Circulation, July 8, 2008; 118(2): 188 - 195. [Full Text] [PDF] |
||||
![]() |
M. G. Keane and R. E. Pyeritz Medical Management of Marfan Syndrome Circulation, May 27, 2008; 117(21): 2802 - 2813. [Full Text] [PDF] |
||||
![]() |
H. Wakiyama, M. Nasu, H. Fujiwara, A. Kitamura, and Y. Okada Two Surgical Cases of Acute Aortic Dissection in Pregnancy with Marfan Syndrome Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): e63 - e65. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Radermecker, R. Durieux, J.-L. Canivet, and R. Limet Metachronous type III and type II acute aortic dissections in puerperium Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 541 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seeburger, F. W. Mohr, and V. Falk Acute Type A Dissection at 17 Weeks of Gestation in a Marfan Patient Ann. Thorac. Surg., February 1, 2007; 83(2): 674 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
A. Hager, H. Kaemmerer, and J. Hess Comment on pregnancy and aortic root growth in the Marfan syndrome Eur. Heart J., November 1, 2005; 26(21): 2346 - 2346. [Full Text] [PDF] |
||||
![]() |
M. Sakaguchi, H. Kitahara, T. Seto, T. Furusawa, D. Fukui, N. Yanagiya, K. Nishimura, and J. Amano Surgery for acute type A aortic dissection in pregnant patients with Marfan syndrome Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 280 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bachet Editorial comment Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 283 - 285. [Full Text] [PDF] |
||||
![]() |
L. J. Meijboom, F. E. Vos, J. Timmermans, G. H. Boers, A. H. Zwinderman, and B. J.M. Mulder Pregnancy and aortic root growth in the Marfan syndrome: a prospective study Eur. Heart J., May 1, 2005; 26(9): 914 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
C E G Head and S A Thorne Congenital heart disease in pregnancy Postgrad. Med. J., May 1, 2005; 81(955): 292 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carrel, L. Beyeler, A. Schnyder, P. Zurmuhle, P. Berdat, J. Schmidli, and F. S. Eckstein Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 671 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S A Thorne Pregnancy in heart disease Heart, April 1, 2004; 90(4): 450 - 456. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |